Latest news
F&O Query: Analysis of BSE and Lupin futures - BusinessLineBusinessLine · Sat, 08 Aug 2026 15:25:13 GMTLupin bets Biosimilars to cross $100 Mn scale in 3 years; plans in-licensing to innovate India biz - ET PharmaET Pharma · Fri, 07 Aug 2026 14:54:08 GMTLupin Q1 Profit Rises 16% Amid Strong Performance in Key Markets - Pharmacy BusinessPharmacy Business · Fri, 07 Aug 2026 11:48:26 GMTLupin Reports Q1 Financial Results Amid Strong US Sales - India News NetworkIndia News Network · Fri, 07 Aug 2026 08:55:59 GMTLupin Q1 Results 2027: PAT Rises 16% to ₹1,417 Crore, Revenue Up 32% - SahiSahi · Fri, 07 Aug 2026 07:52:27 GMTlupin q1fy27 revenue jumps 33 to 8 217 cr ebitda surges 49 driven by robust us and global growth - ICICI DirectICICI Direct · Fri, 07 Aug 2026 04:16:50 GMTLupin Shares Rise After Q1 Profit, Revenue Beat Street Estimates - NDTV ProfitNDTV Profit · Fri, 07 Aug 2026 03:51:21 GMTAfter Crushing Q1 Estimates, What's Next For Lupin? Macquarie Makes Its Case - NDTV ProfitNDTV Profit · Fri, 07 Aug 2026 03:13:30 GMT